Preparation and Evaluation of Rivastigmine Liposomes for Intranasal Delivery
Author:
- 1 July 2021
- book chapter
- Published by Springer Nature
- p. 325-344
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogelJournal of Pharmacy and Pharmacology, 2013
- Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriersAdvanced Drug Delivery Reviews, 2008
- Strategies to improve tolerability of rivastigmine: a case seriesCurrent Medical Research and Opinion, 2006
- Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing miceJournal of Controlled Release, 2006
- Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugateBioorganic & Medicinal Chemistry Letters, 2004
- A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226‐90 in rat brain and plasma by reversed‐phase liquid chromatography coupled to electrospray ionization mass spectrometryBiomedical Chromatography, 2003
- Nasal drug delivery—possibilities, problems and solutionsJournal of Controlled Release, 2003
- Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 ratsJournal of Neural Transmission, 2002
- RivastigmineDrugs & Aging, 1998
- Absorption of drugs from the nasal mucosa of ratInternational Journal of Pharmaceutics, 1981